Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions of naturally occurring hormones involved in bloodlevel regulation. These novel agents demonstrate substantial efficacy in improving

The management of diabetes has become with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and may improve the lives of individuals living with diabetes. This novel cl